Sign in with Facebook
Or use your Businessweek account
Or use your Businessweek account
Already a Bloomberg.com user?
Sign in with the same account.
Focus On Health Care
Pharma Pipelines, by the Numbers
Focus On Health Care
Pharma Pipelines, by the Numbers
Europe’s pharma pipeline disclosure is more detailed than in the U.S., where drugs in phase I trials are not always disclosed. This means counting the total number of drugs in development is more accurate in Europe.
Feed
Most Popular
- 'Saturday Night Live' Nails the Gun Control Debate
- What Will Immigration Reform Do to America's Worst Workplaces?
- Asustek Beats Amazon on Tablets
- Millions Watch Netflix Without Paying
- The Glock Divorce Comes to America, Revealing New Details About the Gunmaker
- Intel's Too-Modest Proposal for Its New CEO
- Audi Wants to Change a 45-Year-Old U.S. Headlight Rule
- Howrey's Bankruptcy and Big Law Firms' Small Future
- Mexico: The Stranger Next Door
- Howrey's Bankruptcy and Big Law Firms' Small Future
- Scientists Discover a Brain Region That Controls Aging
- Crunch Your Own Facebook Data
- The Latest Corporate Mania: Snagging 'Passive' Job Candidates
- Sriracha Hot Sauce Catches Fire, Yet 'There's Only One Rooster'
- What Will Immigration Reform Do to America's Worst Workplaces?
- Saturday Night Live Nails the Gun Control Debate
- What Germany Can Teach the U.S. about Vocational Education
- Jerry Brown, California's Grownup Governor
- What Will Immigration Reform Do to America's Worst Workplaces?
- Why the Fed Worries Inflation Is Too Low
- An Ex-Wife Threatens Steve Wynn’s Casino Empire
- How Did the World's Rich Get That Way? Luck
- A DOJ Memo Shows Why the NRA Wins on Gun Control
Ads by Google
Post a Job Industries Jobs
- Accounting jobs
- Advertising jobs
- Business Development jobs
- Consulting jobs
- Public Relations jobs
- Executive jobs
- Pharmaceutical jobs
- Legal jobs
- Marketing jobs
- Media jobs
- Non-profit jobs
- Sales jobs
Elsewhere on Businessweek.com
-
Fix This/Water
-
Self-Destructing Media Trend Arrives on Twitter
-
The Worst Reason to Go to War in Syria
-
What Does Manchester United Do With Revenue?
-
Porn Rivals Make Nice After Antitrust Fight
-
Twitter Wants Small Businesses to Buy DIY Ads
-
Facebook Sits on Cash, Will Buy Rivals: Munster
-
'Peak Oil' Is Back, but This Time It's a Peak in Demand
-
The Pampered World of Congressional Air Travel
-
Google Glass Review: A Developer's First Impression
-
Tom Steyer: The Wrath of a Green Billionaire
-
Best Undergraduate Business Schools 2013
Links
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC Ad Choices